Mayne Pharma gains momentum as DistributeRx launches strong
Mayne Pharma (ASX:MYX) recorded a rise in commercial momentum for the third quarter of FY26.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Mayne Pharma (ASX:MYX) recorded a rise in commercial momentum for the third quarter of FY26.
Aged care giant Regis Healthcare (ASX:REG) has appointed Andrew Kinkade as its next CEO.
Medical Developments International (ASX:MVP) reported a 19% year-on-year revenue surge, reaching $10.5 million.
Cambium Bio (ASX:CMB) announced that the US Food and Drug Administration confirmed a streamlined approval pathway for its flagship candidate, Elate Ocular.
Nyrada (ASX:NYR) announced the activation of its first clinical trial site for the PROTECT-MI Phase 2a study.
Australian Health Minister Mark Butler is set to announce the removal of out-of-pocket costs for essential aged-care services.
Invion (ASX:IVX) announced the expansion of its clinical trial for INV043, moving into the final stage of its current non-melanoma skin cancer study.
Recce Pharmaceuticals (ASX:RCE) achieves a regulatory milestone as Indonesia's BPOM clears its Phase 3 clinical trial site for diabetic foot infection treatment.
Nexalis Therapeutics (ASX:NX1) announced a clinical breakthrough with the screening of the first patient in its Phase 2 clinical trial for IRX-211.
Radiopharm Theranostics (ASX:RAD) unveiled initial data from its Phase 1 "HEAT" first-in-human clinical trial.
4DMedical (ASX:4DX) announced a new strategic contract with pharmaceutical giant GlaxoSmithKline.
Monash IVF Group (ASX:MVF) has rejected a revised, unsolicited takeover bid from a consortium led by Genesis Capital and Washington H. Soul Pattinson (ASX:SOL).
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade